Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
047
|
Date of Entry 08/21/2017
|
FR Recognition Number
|
13-91
|
Standard | |
ISO IEEE 11073-10419 First edition 2016-06-15 Health informatics - Personal health device communication - Part 10419: Device specialization - Insulin pump |
|
Scope/AbstractThis standard establishes a normative definition of communication between personal telehealth insulin pump devices (agents) and managers (e.g., cell phones, personal computers, personal health appliances, set top boxes) in a manner that enables plug-and-play interoperability. It leverages work done in other ISO/IEEE11073 standards including existing terminology, information profiles, application profile standards, and transport standards. It specifies the use of specific term codes, formats, and behaviors in telehealth environments, restricting optionality in base frameworks in favor of interoperability. This standard defines a common core functionality of personal telehealth insulin pump devices. In the context of personal health devices (PHDs), an insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion (CSII) therapy. This standard provides the data modeling according to ISO/IEEE 11073-20601 and does not specify the measurement method. |
|
Extent of Recognition
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§880.5725 |
Pump, Infusion, Insulin
|
Class 2
|
LZG
|
§880.5725 |
Pump, Infusion, Insulin Bolus
|
Class 2
|
OPP
|
N/A |
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor |
Class 3
|
OYC
|
N/A |
Automated Insulin Dosing , Threshold Suspend |
Class 3
|
OZO
|
N/A |
Automated Insulin Dosing Device System, Single Hormonal Control |
Class 3
|
OZP
|
|
Relevant FDA Guidance and/or Supportive Publications*
Guidance for Industry and Food and Drug Administration Staff - The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems issued November 9, 2012.
Guidance on the Content of Premarket Notification [510(k)] Submissions for External Infusion Pumps issued March 1, 1993.
Infusion Pumps Total Product Life Cycle - Guidance for Industry and FDA Staff issued December 2, 2014.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organizations
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |